D-0120 Safety and PK/PD Study in China
NCT03923868
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperuricemia or Gout
Interventions
DRUG:
D-0120
Sponsor
InventisBio Co., Ltd